Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease-A Double Blinded RCT
Authors not listed
Institute of Liver and Biliary Sciences, India · 2021
Abstract
Sarcopenia is now a well-known complication of cirrhosis and various studies, including pediatric studies, have recognized it as a poor prognostic factor. At the molecular level, branch chain amino acids upregulate muscle protein synthesis by acting through the mTOR(definition) pathway. Although effect of Branch Chain Amino acids has been studied extensively with respect to hepatic encephalopathy in cirrhotic adults, there is paucity of literature on the effect of BCAA on sarcopenia and frailty. Also, there is very limited data on the effect of BCAA therapy in children with chronic liver disease. Through this study, we aim to assess the effect of BCAA therapy on Mid Arm Muscle Area in cirrhotic children after 12 weeks. Our secondary objective will be to study the prevalence of sarcopenia in children with CLD using cut-off as Mid Arm Muscle area less than 2SD (using published centiles) and muscle thickness (quadriceps and biceps) on ultrasound, and to study serum follistatin levels in those with or without sarcopenia. Other secondary objectives will include determination of mTOR gene expression at baseline and 7 days of BCAA therapy and change in creatinine height index after 12 weeks of BCAA therapy, occurrence of clinically significant events in the BCAA group vs placebo group and to study the increase in MAMA and USG muscle thickness after 6 months of BCAA therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Anonymous. (2021). Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease-A Double Blinded RCT. <em>Institute of Liver and Biliary Sciences, India</em>. https://clinicaltrials.gov/study/NCT05093218
Vancouver
Anonymous. Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease-A Double Blinded RCT. Institute of Liver and Biliary Sciences, India. 2021.
BibTeX
@misc{anon2021Effect,
title = {Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease-A Double Blinded RCT},
author = {Anonymous},
journal = {Institute of Liver and Biliary Sciences, India},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Institute of Liver and Biliary Sciences, India 2023
Open access · US-GOV
Effect of Exercise Based Regimen on Frailty in Children With Liver Disease -A Randomized Controlled Trial
Centre Hospitalier Régional d'Orléans 2024
Open access · US-GOV
Follow up of Strength and Body Composition With Impedancemeter Device During the First 10 Days After Acute Stroke.
2016
Open access · OA
MITOCHONDRIA AND OXIDATIVE STRESS IN AGE-RELATED MUSCLE LOSS (SARCOPENIA)
Elsevier eBooks 2016
Citation only
The Aging Muscle and Sarcopenia
Elsevier eBooks 2019
Citation only
Aging Muscle and Sarcopenia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2023
Open access · US-GOV